Key Points
Research suggests Trump's tariffs are likely impacting US-based orthopedic medical device companies, increasing costs and disrupting supply chains.
It seems likely that orthopedic devices face a 10% global tariff and higher reciprocal tariffs, with China's effective rate at 54% as of April 9, 2025.
The evidence leans toward higher prices for patients and potential job losses, with industry groups lobbying for exemptions without success as of April 11, 2025.
Background
President Donald Trump's tariff policies, announced in early 2025, introduced a 10% global tariff on all imports, effective April 5, 2025, and additional reciprocal tariffs of 11% to 50% on 57 countries, effective April 9, 2025. On April 9, 2025, a 90-day pause was announced on most reciprocal tariffs, leaving the 10% baseline in effect, but China's tariffs were raised to 125% immediately, later clarified as an effective rate of 54% due to existing tariffs Trump announces 90-day reprieve on reciprocal tariffs, but bumps China's to 125%. These measures aim to address trade deficits but have raised concerns for US-based orthopedic medical device companies, which rely on global supply chains for components ...
